Effective July 1, 2018, all gabapentin products will be Schedule V controlled substances in the state of Tennessee. It is known under the brand names Neurontin, Horizant, Gralise, Gabarone, and Fanatrex. Gabapentin is often used to potentiate the effects of opioids and potentially increases the risk of overdose death when used in combination with them. The US has seen substantial increases in the rate of gabapentin prescribing and abuse, leading to this change. The new scheduling of gabapentin will not only affect patients, but pharmacists and pharmacy technicians as well.  Read more…